This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,311.35 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, with a period of performance through September 18, 2024.
This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program. The IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of Department of Defense healthcare facilities worldwide. This contract has no set-aside designation and leverages DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for pharmaceutical prime vendor programs supporting military medical facilities globally.
Generated 12/17/24, 9:12 AM